Search Results

Filter
  • 1-10 of  133,186 results for ""AMITRIPTYLINE""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Factors associated with the use of traditional doses of amitriptyline for chronic pain management: A cross-sectional study.

  • Authors : Koo H; College of Pharmacy, Chung-Ang University, Seoul, Korea.; Jeong KH

Subjects: Amitriptyline*/Amitriptyline*/Amitriptyline*/therapeutic use ; Chronic Pain*/Chronic Pain*/Chronic Pain*/drug therapy; Humans

  • Source: Medicine [Medicine (Baltimore)] 2024 Jan 05; Vol. 103 (1), pp. e36790.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Phenotypic and functional assessment of two novel KCNQ2 gain-of-function variants Y141N and G239S and effects of amitriptyline treatment.

  • Authors : Bayat A; Department of Epilepsy Genetics and Personalized Medicine, Danish Epilepsy Center, Filadelfia, Dianalund, Denmark; Department for Regional Health Research, University of Southern Denmark, Odense, Denmark

Subjects: Amitriptyline* ; Epilepsy*; Infant, Newborn

  • Source: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics [Neurotherapeutics] 2024 Jan; Vol. 21 (1), pp. e00296. Date of Electronic Publication: Publisher: Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics Country of Publication: United States NLM ID: 101290381 Publication

Record details

×
Academic Journal

Amitriptyline as second-line treatment for IBS in primary care settings.

  • Authors : Ray K; Nature Reviews Gastroenterology & Hepatology, . .

Subjects: Amitriptyline*/Amitriptyline*/Amitriptyline*/therapeutic use ; Irritable Bowel Syndrome*; Humans

  • Source: Nature reviews. Gastroenterology & hepatology [Nat Rev Gastroenterol Hepatol] 2024 Jan; Vol. 21 (1), pp. 2.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101500079 Publication Model: Print Cited Medium: Internet ISSN: 1759-5053

Record details

×
Academic Journal

Amitriptyline efficacy in decreasing implant-induced foreign body reaction.

  • Authors : Scheuermann K; Department of General Pathology, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.; Viana CTR

Subjects: Amitriptyline*/Amitriptyline*/Amitriptyline*/pharmacology ; Vascular Endothelial Growth Factor A*/Vascular Endothelial Growth Factor A*/Vascular Endothelial Growth Factor A*/genetics ; Vascular Endothelial Growth Factor A*/Vascular Endothelial Growth Factor A*/Vascular Endothelial Growth Factor A*/metabolism

  • Source: IUBMB life [IUBMB Life] 2023 Sep; Vol. 75 (9), pp. 732-742. Date of Electronic Publication: 2023 Apr 22.Publisher: Published for the International Union of Biochemistry and Molecular Biology by Taylor & Francis Country of Publication: England NLM ID: 100888706

Record details

×
Academic Journal

Cost-minimization analysis of escitalopram, fluoxetine, and amitriptyline in the treatment of depression.

  • Authors : Salian HH; Department of Psychiatry, AIIMS, Vijaypur, Jammu, India.; Raghav MV

Subjects: Fluoxetine*/Fluoxetine*/Fluoxetine*/therapeutic use ; Amitriptyline*/Amitriptyline*/Amitriptyline*/therapeutic use; Humans

  • Source: Indian journal of pharmacology [Indian J Pharmacol] 2023 Sep-Oct; Vol. 55 (5), pp. 293-298.Publisher: Medknow Publications Country of Publication: India NLM ID: 7902477 Publication Model: Print Cited Medium: Internet ISSN: 1998-3751

Record details

×
Academic Journal

TCF7L2: A potential key regulator of antidepressant effects on hippocampal astrocytes in depression model mice.

  • Authors : Koga Y; Department of Neuropsychiatry, Faculty of Life Sciences, Kumamoto University, 1-1-1, Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.; Kajitani N

Subjects: Amitriptyline*/Amitriptyline*/Amitriptyline*/pharmacology ; Amitriptyline*/Amitriptyline*/Amitriptyline*/metabolism ; Astrocytes*/Astrocytes*/Astrocytes*/metabolism

  • Source: Journal of psychiatric research [J Psychiatr Res] 2024 Feb; Vol. 170, pp. 375-386. Date of Electronic Publication: 2024 Jan 06.Publisher: Pergamon Press Country of Publication: England NLM ID: 0376331 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Off-label low dose amitriptyline for insomnia disorder: Patient-reported outcomes.

  • Authors : Bakker MH; Department of General Practice, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.; Research programme Quality of Care, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.

Subjects: Amitriptyline*/Amitriptyline*/Amitriptyline*/adverse effects ; Sleep Initiation and Maintenance Disorders*/Sleep Initiation and Maintenance Disorders*/Sleep Initiation and Maintenance Disorders*/drug therapy; Humans

  • Source: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2023 Apr; Vol. 32 (4), pp. 435-445. Date of Electronic Publication: 2022 Nov 20.Publisher: Wiley Country of Publication: England NLM ID: 9208369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-1557

Record details

×
Editorial & Opinion

Amitriptyline for fibromyalgia: Off-label treatment, but non-inferior to approved medication.

  • Authors : Hung CH; Department of Pharmacy, Chang Bing Show Chwan Memorial Hospital, Changhua, Taiwan.; Lee YH

Subjects: Amitriptyline*/Amitriptyline*/Amitriptyline*/adverse effects ; Fibromyalgia*/Fibromyalgia*/Fibromyalgia*/diagnosis ; Fibromyalgia*/Fibromyalgia*/Fibromyalgia*/drug therapy

  • Source: International journal of rheumatic diseases [Int J Rheum Dis] 2023 Apr; Vol. 26 (4), pp. 607-608.Publisher: Wiley on behalf of the Asia Pacific League of Associations for Rheumatology Country of Publication: England NLM ID: 101474930 Publication Model:

Record details

×
Academic Journal

European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention-part 1: amitriptyline.

  • Authors : Lampl C; Department of Neurology and Stroke Unit, Konventhospital Barmherzige Brüder Linz, Linz, Austria. .; Headache Medical Center Linz, Linz, Austria. .

Subjects: Amitriptyline*/Amitriptyline*/Amitriptyline*/adverse effects ; Migraine Disorders*/Migraine Disorders*/Migraine Disorders*/prevention & control ; Migraine Disorders*/Migraine Disorders*/Migraine Disorders*/drug therapy

  • Source: The journal of headache and pain [J Headache Pain] 2023 Apr 11; Vol. 24 (1), pp. 39. Date of Electronic Publication: 2023 Apr 11.Publisher: BioMed Central Country of Publication: England NLM ID: 100940562 Publication Model: Electronic Cited Medium: Internet ISSN: 1129-2377

Record details

×
Academic Journal

In brief: Off-label amitriptyline for insomnia.

Subjects: Amitriptyline* ; Sleep Initiation and Maintenance Disorders*/Sleep Initiation and Maintenance Disorders*/Sleep Initiation and Maintenance Disorders*/drug therapy; Humans

  • Source: The Medical letter on drugs and therapeutics [Med Lett Drugs Ther] 2023 Mar 20; Vol. 65 (1672), pp. 48.Publisher: The Medical Letter Country of Publication: United States NLM ID: 2985240R Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  133,186 results for ""AMITRIPTYLINE""